Clinical Trial Update: A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase I/II open-label trial evaluating adding ofatumumab to chlorambucil in previously untreated Japanese patients with chronic lymphocytic leukemia; Phase 2 re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Arzerra (ofatumumab)
• Leukeran (chlorambucil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2015-08-10